Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of combining alvocidib, irinotecan hydrochloride,
and cisplatin in treating patients who have advanced solid tumors. Drugs used in chemotherapy
use different ways to stop tumor cells from dividing so they stop growing or die. Combining
more than one drug may kill more tumor cells.